comparemela.com

Latest Breaking News On - Abbott pathology - Page 1 : comparemela.com

HLS ASX: Australian Clinical labs, the No 3 player in Australia s pathology market, withdrew a takeover bid for No 2 player Healius after the ACCC blocked a merger, but has not given up entirely

Australian Clinical Labs, the No.3 player in the pathology market, has not given up in its chase for ailing No.2 player Healius.

Insider Buying: Healius Limited (ASX:HLS) Insider Buys A$80,560 00 in Stock

Healius Limited (ASX:HLS – Get Free Report) insider Kathryn (Kate) McKenzie bought 53,000 shares of Healius stock in a transaction on Monday, December 4th. The stock was acquired at an average cost of A$1.52 ($1.01) per share, with a total value of A$80,560.00 ($53,350.99). Healius Stock Performance The company has a current ratio of 0.55, […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.